| US 7,601,128 B2 | ||
| Apparatus for treating subcutaneous tissues | ||
| Mark E. Deem, Mountain View, Calif. (US); Hanson S. Gifford, III, Woodside, Calif. (US); and Douglas Sutton, Pacifica, Calif. (US) | ||
| Assigned to Cabochon Aesthetics, Inc., Menlo Park, Calif. (US) | ||
| Filed on Jan. 17, 2006, as Appl. No. 11/334,805. | ||
| Application 11/334805 is a continuation of application No. 11/292950, filed on Dec. 02, 2005. | ||
| Claims priority of provisional application 60/715398, filed on Sep. 07, 2005. | ||
| Prior Publication US 2007/0055181 A1, Mar. 08, 2007 | ||
| Int. Cl. A61H 1/00 (2006.01); A61H 1/02 (2006.01); A61H 5/00 (2006.01) | ||
| U.S. Cl. 601—2 [601/3; 604/506; 604/511; 604/518] | 28 Claims |
| 1. An assembly for treating subcutaneous tissue and reducing cellulite, comprising:
an acoustic wave generator for generating unfocused acoustic waves;
an acoustic wave transducer operably connected to the acoustic wave generator and configured to apply the unfocused acoustic
waves to the subcutaneous tissue of a patient from a point above and external to a dermis of the patient;
a source of a microbubble solution; and
a plurality of non-vibrating solution injection members operably connected to said source of microbubble solution, said plurality
of non-vibrating solution injection members being equally spaced apart and configured to percutaneously inject the microbubble
solution into a treatment area located between 1 mm and 5 mm below the dermis,
wherein the apparatus is configured to produce irreversible subcutaneous cavitational bioeffects in a substantial amount of
the microbubble solution-infused subcutaneous tissue in the treatment area and configured to leave cells outside the treatment
area unaffected to contour a portion of an outer surface of the dermis and to reduce the cellulite.
|